Protection by amylin of gastric erosions induced by indomethacin or ethanol in rats

British Journal of Pharmacology

Volumn 120, Issue 4, 1997, Pages 581-586

  Guidobono, F ^a,b   Pagani, F ^a   Ticozzi, C ^a   Sibilia, V ^a   Pecile, A ^a   Netti, C ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Chemother Med T   (Italy)

Author keywords

Amylin; Brain; Ethanol; Indomethacin; Ulcers

Indexed keywords

ALCOHOL; AMYLIN; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROSTAGLANDIN; PROSTANOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH ACID SECRETION; STOMACH EROSION; STOMACH MUCOSA; STOMACH ULCER; SUBCUTANEOUS DRUG ADMINISTRATION;

AMYLOID; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; GASTRIC ACIDITY DETERMINATION; GASTRIC MUCOSA; INDOMETHACIN; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SUBCUTANEOUS; MALE; NG-NITROARGININE METHYL ESTER; RATS; RATS, SPRAGUE-DAWLEY; STOMACH ULCER;

EID: 0031053785     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0700941     Document Type: Article

References (40)

1. ADAMI, R., MARAGGI-UBERTI, E. & TURBA, C. (1964). Pharmacological research on gefarnate, a new synthetic isoprenoid with antiulceration activity. Int. Pharmacodyn. Ther., 147, 113-118.
2. BEAUMONT, K., MOORE, C.X., PITTNER, R.A., PRICKETT, K.S., GAETA, L.S.L., RINK, T.J. & YOUNG, A.A. (1995). Differential antagonism of amylin's metabolic and vascular actions with amylin receptor antagonists. Can. J. Physiol. Pharmacol., 73, 1025-1029.
3. BHOGAL, R., SMITH, D.M. & BLOOM, S.R. (1992). Investigation and characterization of binding sites for islet amyloid polypeptide in rat membranes. Endocrinology, 130, 906-913.
4. BRAIN, S.D., WIMALAWANSA, S., MACINTYRE, I. & WILLIAMS, T.J. (1990). The demonstration of vasodilator activity of amylin amide in the rat. Am. J. Pathol., 136, 487-490.
5. BUTLER, P.C., CHOU, J., CARTES, W.B., WANG, Y.N., BU, B.M., CHANG, D., CHANG, J.K. & RIZZA, R.A. (1990). Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes, 39, 752-756.
6. CLEMENTI, G., AMICO-ROXAS, M., CARUSO, A., CATENA CUTULI, V.M., MAUGERI, S. & PRATO, A. (1993). Protective effects of calcitonin gene-related peptide in different experimental models of gastric ulcers. Eur. J. Pharmacol., 238, 101-104.
7. CLEMENTI, G., CARUSO, A., PRATO, A., DE BERNARDIS, E., FIORE, C.E. & AMICO-ROXAS, M. (1994). A role for nitric oxide in antiulcer activity of calcitonin gene-related peptide. Eur. J. Pharmacol., 256, R7-R8.
8. COOPER, G.J.S. (1994). Amylin compared with calcitonin gene- related peptide: structure, biology and relevance to metabolic disease. Endocrine Rev., 15, 163-201.
9. COOPER, G.J.S., WILLIS, A.C., CLARK, A., TURNER, R.C., SIM, R.B. & REID, K.M.B. (1987). Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc. Natl. Acad. Sci. U.S.A., 84, 8628-8632.
10. DATTA, H.K., ZAIDI, M., WIMALAWANSA, S.J., GHATEI, M.A., BEACHAM, J.L., BLOOM, S.R. & MACINTYRE, I. (1989). In vivo and in vitro effects of amylin-amide on calcium metabolism in the rat and rabbit. Biochem. Biophys. Res. Commun., 162, 876-881.
11. DEEMS, R.O., DEACON, R.W. & YOUNG, D.A. (1991). Amylin activates glycogen phosphorylase and inactivates glycogen synthasevia a cAMP-independent mechanism. Biochem. Biophys. Res. Commun., 174, 716-720.
12. A receptors. Br. J. Pharmacol., 102, 119-122.
13. EVANGELISTA, S., MAGGI, C.A. & MELI, A. (1987). Influence of peripherally-administered peptides on ethanol-induced gastric ulcers in the rat. Gen. Pharmacol., 18, 647-649.
14. FERRIER, G.J.M., PIERSON, A.M., JONES, P.M., BLOOM, S.R., GIRGIS, S.I. & LEGON, S. (1989). Expression of the rat amylin (IAPP/DAP) gene. J. Mol. Endocrinol., 3, R1-R4.
15. GUIDOBONO, F., COLUZZI, M., PAGANI, F., PECILE, A. & NETTI, C. (1994). Amylin given by central and peripheral routes inhibits acid gastric secretion. Peptides, 15, 699-702.
16. GUIDOBONO, F., NETTI, C., PAGANI, F., BETTICA, P., SIBILIA, V. & PECILE, A. (1991). Effect of unmodified eel calcitonin on gastric acid secretion and gastric ulcers in the rat. Il Farmaco, 46, 555-563.
17. GUIDOBONO, F., NETTI, C., PECILE, A., ZANELLI, J.M. & GAINESDAS, R.E. (1990). Specific inhibition of basal gastric acid secretion by salmon calcitonin in rats does not necessarily involve a central pathway. Pharmacol. Res., 22, 287-295.
18. HOLZER, P., LIPPE, I. Th., JOCIC, M., WACHTER, Ch., ERB, R. & HEINEMANN, A. (1993). Nitric oxide-dependent and -independent hyperaemia due to calcitonin gene-related peptide in the rat stomach. Br. J. Pharmacol., 110, 404-410.
19. HOLZER, P., WACHTER, Ch., HEINEMANN, A., JOCIC, M., LIPPE, I. Th. & HERBERT, M.K. (1995). Diverse interactions of calcitonin gene-related peptide and nitric oxide in the gastric and cutaneous microcirculation. Can. J. Pharmacol., 73, 991-994.
20. 2 receptor antagonist in the rat. Pharmacology, 41, 333-337.
21. LEIGHTON, B. & COOPER, G.J.S. (1988). Pancreatic amylin and calcitonin gene related peptide causes resistance to insulin in skeletal muscle in vitro. Nature, 335, 632-635.
22. MARTIN, M.J., MARHUENDA, E., PEREZ-GUERRERO, C. & FRANCO, J.M. (1994). Antiulcer effect of narginin on gastric lesions induced by ethanol in rats. Pharmacology, 49, 144-150.
23. MITSUKAWA, T., TAKEMURA, J., ASA, I.J., NAKAZATO, M., KANGAWA, K., MATSUO, H. & MATSUKURA, S. (1990). Islet amyloid polypeptide response to glucose, insulin, and somatostatin analogue administration. Diabetes, 39, 639-642.
24. MIYAZATO, M., NAKAZATO, M., SHIOMI, K., ABURAYA, J., TOSHIMORI, H., KANGAMA, K., MATSUO, H. & MATSUKURA, S. (1991). Identification and characterization of islet amyloid polypeptide in mammalian gastrointestinal tract. Biochem. Biophys. Res. Commun., 181, 293-300.
25. MORLEY, J.E. & FLOOD, J.F. (1991). Amylin decreases food intake in mice. Peptides, 12, 865-869.
26. MORLEY, J.E., FLOOD, J.F., FARR, S.A., PERRY III, H.J., KAISER, F.E. & MORLEY, P.M.K. (1995). Effects of amylin on appetite regulation and memory. Can. J. Physiol. Pharmacol., 73, 1042-1046.
27. PITTNER, R.A., ALBRANDT, K., BEAUMONT, K., GAETA, L.S.L., KODA, J.E., MOORE, C.X., RITTENHOUSE, J. & RINK, T.J. (1994) Molecular physiology of amylin. J. Cell Biochem., 55S, 19-28.
28. POYNER, D. (1995). Pharmacology of receptors for calcitonin gene- related peptide and amylin. Trends Pharmacol. Sci., 16, 424-428.
29. RINK, J.T., BEAUMONT, K., KODA, J. & YOUNG, A. (1993). Structure and biology of amylin. Trends Pharmacol. Sci., 14, 113-118.
30. ROBERT, A., NEZAMIS, J.E., LANCASTER, C. & HANCHAR, A.J. (1979). Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl and thermal injury. Gastroenterology, 77, 433-443.
31. SHAY, A.S., KAMAROV, S.S., FELS, D., MERANZE, M., GRUENSTEIN, M. & SIPLET, H. (1945). A simple method for the uniform production of gastric ulceration in the rat. Gastroenterology, 5, 43-46.
32. SHIRAISHI, T. (1988). Hypothalamic control of gastric acid secretion. Brain Res. Bull., 20, 791-797.
33. SKOFITSCH, G., WIMALAWANSA, S.J., JACOBOWlTZ, D.M. & GUBISCH, W. (1995). Comparative immunohistochemical distribution of amylin-like and calcitonin gene-related peptide like immunoreactivity in the rat central nervous system. Can. J. Physiol. Pharmacol., 73, 945-956.
34. TAKEUCHI, K., UESHIMA, K., OHUCHI, T. & OKABE, S. (1994). Induction of gastric lesions and hypoglycemic response by food deprivation in streptozotocin-diabetic rats. Digestive Dis. Sci., 39, 626-634.
35. TALLARIDA, R.J. & MURRAY, R.B. (1981). Manual and Pharmacological Calculations with Computer Programs. New York: Springer-Verlag.
36. TOSHIMORI, H., NARITA, R., NAKAZATO, M., ASA, I.J., MITSUKAWA, T., KANGAWA, K., MATSUO, H. & MATSUKURA, S. (1990). Islet amyloid polypeptide (IAPP) in the gastrointestinal tract and pancreas of man and rat. Cell Tissue Res., 262, 401-406.
37. 125I] BHr AMY) specific binding sites in the rat brain. Can. J. Physiol. Pharmacol., 73, 1084-1088.
38. WESTERMARK, P., WERNSTEDT, C., WILANDER, E., HAYDEN, D.W., O'BRIEN, T.D. & JOHNSON, K.H. (1987a). Amyloid fibrils in human insulinoma and islets of Langherans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc. Natl. Acad. Sci. U.S.A., 84, 3881-3885.
39. WESTERMARK, P., WILANDER, E., WESTERMARK, G.T. & JOHNSON, K.H. (1987b). Islet Amyloid polypeptide-like immunoreactivity in the islet B cells of type 2 (non-insulin-dependent) diabetic and non-diabetic individuals. Diabetologia, 30, 887-892.
40. YOUNG, D.A., DEEMS, R.O., DEACON, R.W., MCINTOSH, R.H. & FOLEY, J.E. (1990). Effects of amylin on glucose metabolism and glycogenolysis in vivo and in vitro. Am. J. Physiol., 259, E457- E461.